Results 81 to 90 of about 2,190 (195)
Formulation and Physicochemical Characterization of Magnetic Nanoparticles Containing Brimonidine for Ophthalmic Drug Delivery [PDF]
Introduction: Recently, magnetic nanoparticles (MNPs) drew a great attention for application in drug delivery systems. Due to their biocompatibility and non-toxic properties, they have potential to create versatile drug delivery systems.
Afsharipour, Sepehr +4 more
core +2 more sources
A review on polymers in ocular drug delivery systems
Polymers play a pivotal role in ocular drug delivery, revolutionizing treatment approaches. These biomaterials enable controlled and sustained drug release at the targeted site, enhancing bioavailability and patient compliance. From nanosized particle‐based formulations to in situ gelation mechanisms, polymers offer improved treatment options for a ...
Amol C. Bisen +10 more
wiley +1 more source
FetoML: Interpretable predictions of the fetotoxicity of drugs based on machine learning approaches
Abstract Pregnant females may use medications to manage health problems that develop during pregnancy or that they had prior to pregnancy. However, using medications during pregnancy has a potential risk to the fetus. Assessing the fetotoxicity of drugs is essential to ensure safe treatments, but the current process is challenged by ethical issues ...
Myeonghyeon Jeong, Sunyong Yoo
wiley +1 more source
This review discusses covalent organic frameworks (COFs) as promising drug carriers for cancer treatment, emphasizing their advantageous structures and biocompatibility. It highlights advancements in donor‐acceptor COFs for targeted delivery and fluorescence‐aided cell uptake, while also considering the challenges in pore geometry customization.
Fariba Mehvari +6 more
wiley +1 more source
Clinical efficacy of treatment for subclinical-stage axial diabetic optic neuropathy
Background: There is no standard of therapy for the treatment of diabetic optic neuropathy (DON). Purpose: To assess the clinical efficacy of thioctic acid, topical brimonidine tartrate and a combination of vitamins В1, В6, and В12 in the management ...
M.A. Karliychuk, P.A. Bezditko
doaj +1 more source
Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management [PDF]
The review summarizes and systemizes available international data on the pathogenesis, clinical manifestations and current recommendations for the management of rosacea ...
Del Rosso J.Q.
core +2 more sources
Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops [PDF]
Brimonidine tartrate (BT) (Alphagan) is an α-2 adrenergic agonist marketed for treatment of primary open angle glaucoma (POAG) which may have neuroprotective effects.1 One report of acute delusional psychosis with auditory hallucinations in a 68 year old man treated for POAG has been published,2 and use of BT eye drops in an infant resulted in coma and
openaire +1 more source
Treating Glaucoma with Porous Contact Lens
Glaucoma is a family of diseases that afflicts 65 million people worldwide. Primary open angle glaucoma is the most common type of glaucoma. This is characterized by increased intraocular pressure (IOP) within the eye that results in vision loss. Current
Adams, Amie +3 more
core
Glaucoma agudo de ângulo fechado, bilateral, desencadeado pelo topiramato: relato de caso [PDF]
This paper describes a topiramate induced acute bilateral angle-closure glaucoma. This rare adverse effect is an idiosyncratic reaction characterized by uveal effusion and lens forward displacement, leading to increased intraocular pressure and vision ...
Abreu Neto, José Maria +3 more
core +1 more source
Toyoaki Tsumura,1 Keiji Yoshikawa,2 Tairo Kimura,3 Hirotaka Suzumura,4 Miwako Kawashima,5 Mami Nanno,6 Kiyotaka Ishijima,7 Ryuji Takeda8 1Fussa Hospital, Tokyo, Japan; 2Yoshikawa Eye Clinic, Tokyo, Japan; 3Ueno Eye Clinic, Tokyo, Japan; 4Suzumura Eye ...
Tsumura T +7 more
doaj

